Comprehensive diagnosis and care
In the United States, 1 in 6 men will be diagnosed with prostate cancer. After skin cancer, prostate cancer is the most common type of cancer in American men. Approximately 221,000 new cases of prostate cancer are diagnosed each year.
Detecting Prostate Cancer
Early detection for prostate cancer begins with a physical examination (your physician inserts a gloved finger into the anus and feels for abnormalities) and a prostate specific antigen (PSA) blood test. Talk with your doctor about whether you should begin PSA screening.
Deciding to screen for prostate cancer is a personal decision. The American Urology Association recommends that doctors discuss the benefits and risks of PSA testing with men at a certain age or in high-risk groups. Doctors should help men make their own decisions about screening, based on age, risk factors, life expectancy and personal preferences.
The American Urology Association does not recommend routine screening for men between ages 40 to 54 years at average risk. Factors that increase your risk include African American heritage and a family history of the disease.
If you undergo a PSA screen and abnormalities are detected, your doctor may request an Ultrasound Guided Biopsy. In this procedure, physicians use a transrectal ultrasound to guide and insert a narrow needle through the rectal wall and into several areas of the prostate to remove tissue samples for testing.
If tests confirm prostate cancer, your physicians will perform additional tests and scans to determine if the cancer has spread to other parts of the body.
Prostate Cancer Treatments
Our team of cancer experts customizes cancer treatment plans for each patient. Treatment plans may include prostate surgery, radiation therapy and/or chemotherapy.
- Open Surgery: Traditional prostatectomy surgery involves removing the entire prostate.
- Robotic Surgery: We offer minimally invasive, robotic-assisted prostate surgery.
- Cryosurgery: A probe is inserted into your prostate to freeze your prostate and kill cancer cells. Long-term impotence is a possible side effect.
- Provenge: Provenge is the first and only FDA-approved immunotherapy for advanced prostate cancer. Aurora BayCare is among the first sites in the nation certified to offer Provenge immunotherapy.
- Xofigo: This treatment involves an intravenous injection of the radioactive material radium 223. It is used to treat prostate cancer that is resistant to treatments that lower testosterone and has spread to your bones, but not to other parts of your body